Sandi See Tai's most recent trade in Lexeo Therapeutics Inc. was a trade of 367 Common Stock done at an average price of $2.8 . Disclosure was reported to the exchange on May 16, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lexeo Therapeutics Inc. | Sandi See Tai | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 2.77 per share. | 16 May 2025 | 367 | 59,242 | - | 2.8 | 1,018 | Common Stock |
| Lexeo Therapeutics Inc. | Sandi See Tai | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 2.61 per share. | 14 Mar 2025 | 5,720 | 59,609 | - | 2.6 | 14,929 | Common Stock |
| Lexeo Therapeutics Inc. | Sandi See Tai | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 4.41 per share. | 19 Feb 2025 | 1,486 | 53,889 | - | 4.4 | 6,558 | Common Stock |
| Lexeo Therapeutics Inc. | Sandi See Tai | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2025 | 77,500 | 77,500 | - | - | Stock Option (right to buy) | |
| Lexeo Therapeutics Inc. | Sandi See Tai | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2025 | 38,750 | 55,375 | - | 0 | Common Stock |